AI assistant
Sending…
ClearPoint Neuro, Inc. — Director's Dealing 2015
Dec 21, 2015
32641_dirs_2015-12-21_88edb7d2-771b-4cab-9b31-e78b1da511c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MRI INTERVENTIONS, INC. (MRIC)
CIK: 0001285550
Period of Report: 2015-12-18
Reporting Person: KOOB CHARLES E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-18 | Common Stock | P | 154035 | — | Acquired | 736931 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-18 | Series A Warrants (right to buy) | $0.4058 | P | 61614 | Acquired | 2020-12-18 | Common Stock (61614) | Indirect |
| 2015-12-18 | Series B Warrants (right to buy) | $0.5275 | P | 46211 | Acquired | 2020-12-18 | Common Stock (46211) | Indirect |
Footnotes
F1: The reported securities are included within 154,035 units purchased by the Koob Family Trust for $0.3246 per unit. Each unit consists of one share of common stock, one series A warrant to purchase 0.40 share of common stock, and one series B warrant to purchase 0.30 share of common stock. The Reporting Person has voting and investment power over the securities held by the Koob Family Trust.
F2: Includes 20,000 shares jointly held with spouse.
F3: The shares subject to this warrant are immediately exercisable.
More from ClearPoint Neuro, Inc.
Regulatory Filings
2026
May 21
Registration Form
2026
May 20
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19